STD Clinic Sues HRSA Over 340B Sites Terminations, Claims Agency Actions Will Force Clinic to Close

Sagebrush Health filed a federal lawsuit against HRSA after the agency terminated the 340B eligibility of several Sagebrush sites for allegedly violating program requirements.
Sagebrush Health, a Nevada-based STD clinic enrolled in the 340B program, has sued the Health Resources and Services Administration (HRSA), [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Hospital Sues HRSA Over 340B Removal, Seeks Retroactive Eligibility

A California-based hospital sued HRSA in the U.S. District Court for the District of Columbia, alleging the agency "unlawfully" prevented the hospital from accessing the 340B program for six months.
A California-based hospital has sued the Health Resources and Services Administration (HRSA), alleging the agency unlawfully prevented it from accessing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri

Key briefs were filed last week in litigation over state contract pharmacy access laws in West Virginia and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sanofi Reinstates Contract Pharmacy Restrictions in Kansas, West Virginia Following State Legal Developments

Sanofi will soon begin restricting 340B contract pharmacy use in Kansas and West Virginia after previously exempting providers in those states.
French pharmaceutical giant Sanofi has reinstated its 340B contract pharmacy restrictions in Kansas and West Virginia following legal developments in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Novartis is Fifth Drugmaker to Sue HRSA to Implement Controversial 340B Rebate Model

Novartis is suing HRSA to impose a controversial 340B rebate model that the agency has not authorized.
Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Terminates 20 ‘Ineligible’ 340B Sites from STD Clinic; Clinic Rejects Allegations and Vows to Fight Back

HRSA has terminated 20 Sagebrush Health sites from the 340B program for allegedly violating program eligibility requirements.
The Health Resources and Services Administration (HRSA) has terminated the 340B status of 20 sites affiliated with the Nevada-based STD [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Appeals in Mississippi and Maryland; Update in Missouri

Key briefs were filed over the past few weeks in litigation over state contract pharmacy access laws in Mississippi, Maryland and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmaker Lawsuit Targets 340B Eligibility of In-Kind STD Clinics; STD Grantee Denies Allegations

Three drugmakers sued HRSA in federal court over 340B eligibility for certain STD clinics, including Sagebrush Health.
Three large drugmakers are suing the federal government for allegedly allowing certain STD clinics to unlawfully participate in the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Fed. Court Rejects AstraZeneca’s Request to Halt Mississippi’s Contract Pharmacy Law, Dealing Another Blow to Drug Industry

A Mississippi federal court has denied AstraZeneca’s request for a preliminary injunction against that state's contract pharmacy access law.
A federal judge this week denied AstraZeneca’s request for a preliminary injunction against Mississippi’s contract pharmacy access law, marking the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ruling Against West Virginia Contract Pharmacy Access Law May Increase Odds of Eventual SCOTUS Review as State Providers Vow to ‘Not Give Up’

A recent federal appeals court ruling against West Virginia's contract pharmacy access law may increase the chances that the U.S. Supreme Court eventually takes up the issue.
A federal judge’s recent ruling against West Virginia’s 340B contract pharmacy law advances the drug industry’s push to bring the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live